Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SBC vs LASE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SBC
SBC Medical Group Holdings Incorporated

Consulting Services

IndustrialsNASDAQ • US
Market Cap$329M
5Y Perf.-68.0%
LASE
Laser Photonics Corporation

Industrial - Machinery

IndustrialsNASDAQ • US
Market Cap$16M
5Y Perf.-72.0%

SBC vs LASE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SBC logoSBC
LASE logoLASE
IndustryConsulting ServicesIndustrial - Machinery
Market Cap$329M$16M
Revenue (TTM)$178M$7M
Net Income (TTM)$43M$-8M
Gross Margin73.7%31.1%
Operating Margin33.3%-126.5%
Forward P/E7.1x
Total Debt$12M$5M
Cash & Equiv.$125M$534K

SBC vs LASELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SBC
LASE
StockSep 22May 26Return
SBC Medical Group H… (SBC)10032.0-68.0%
Laser Photonics Cor… (LASE)10028.0-72.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: SBC vs LASE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SBC leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
SBC
SBC Medical Group Holdings Incorporated
The Income Pick

SBC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 0.76
  • Rev growth 6.1%, EPS growth 15.5%
  • -67.8% 10Y total return vs LASE's -72.0%
Best for: income & stability and growth exposure
LASE
Laser Photonics Corporation
The Specific-Use Pick

In this particular matchup, LASE is outpaced on most metrics by others in the set.

Best for: industrials exposure
See the full category breakdown
CategoryWinnerWhy
GrowthSBC logoSBC6.1% revenue growth vs LASE's -13.3%
Quality / MarginsSBC logoSBC24.3% margin vs LASE's -105.4%
Stability / SafetySBC logoSBCBeta 0.76 vs LASE's 1.68, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)SBC logoSBC+0.3% vs LASE's -74.1%
Efficiency (ROA)SBC logoSBC13.5% ROA vs LASE's -43.1%, ROIC 72.3% vs -42.1%

SBC vs LASE — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLSBCLAGGINGLASE

Income & Cash Flow (Last 12 Months)

SBC leads this category, winning 5 of 6 comparable metrics.

SBC is the larger business by revenue, generating $178M annually — 25.0x LASE's $7M. SBC is the more profitable business, keeping 24.3% of every revenue dollar as net income compared to LASE's -105.4%. On growth, LASE holds the edge at +28.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSBC logoSBCSBC Medical Group…LASE logoLASELaser Photonics C…
RevenueTrailing 12 months$178M$7M
EBITDAEarnings before interest/tax$62M-$8M
Net IncomeAfter-tax profit$43M-$8M
Free Cash FlowCash after capex-$37M-$4M
Gross MarginGross profit ÷ Revenue+73.7%+31.1%
Operating MarginEBIT ÷ Revenue+33.3%-126.5%
Net MarginNet income ÷ Revenue+24.3%-105.4%
FCF MarginFCF ÷ Revenue-20.5%-58.7%
Rev. Growth (YoY)Latest quarter vs prior year-18.3%+28.3%
EPS Growth (YoY)Latest quarter vs prior year+3.2%-7.4%
SBC leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

LASE leads this category, winning 2 of 3 comparable metrics.
MetricSBC logoSBCSBC Medical Group…LASE logoLASELaser Photonics C…
Market CapShares × price$329M$16M
Enterprise ValueMkt cap + debt − cash$216M$21M
Trailing P/EPrice ÷ TTM EPS6.65x-3.29x
Forward P/EPrice ÷ next-FY EPS est.7.07x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple2.92x
Price / SalesMarket cap ÷ Revenue1.60x4.70x
Price / BookPrice ÷ Book value/share1.59x0.90x
Price / FCFMarket cap ÷ FCF19.17x
LASE leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

SBC leads this category, winning 8 of 9 comparable metrics.

SBC delivers a 17.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-184 for LASE. SBC carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to LASE's 0.49x. On the Piotroski fundamental quality scale (0–9), SBC scores 7/9 vs LASE's 1/9, reflecting strong financial health.

MetricSBC logoSBCSBC Medical Group…LASE logoLASELaser Photonics C…
ROE (TTM)Return on equity+17.5%-183.5%
ROA (TTM)Return on assets+13.5%-43.1%
ROICReturn on invested capital+72.3%-42.1%
ROCEReturn on capital employed+37.9%-45.9%
Piotroski ScoreFundamental quality 0–971
Debt / EquityFinancial leverage0.06x0.49x
Net DebtTotal debt minus cash-$113M$4M
Cash & Equiv.Liquid assets$125M$533,871
Total DebtShort + long-term debt$12M$5M
Interest CoverageEBIT ÷ Interest expense596.05x-6.60x
SBC leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SBC leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in SBC five years ago would be worth $3,223 today (with dividends reinvested), compared to $2,805 for LASE. Over the past 12 months, SBC leads with a +0.3% total return vs LASE's -74.1%. The 3-year compound annual growth rate (CAGR) favors SBC at -32.2% vs LASE's -38.4% — a key indicator of consistent wealth creation.

MetricSBC logoSBCSBC Medical Group…LASE logoLASELaser Photonics C…
YTD ReturnYear-to-date-25.9%-63.8%
1-Year ReturnPast 12 months+0.3%-74.1%
3-Year ReturnCumulative with dividends-68.9%-76.6%
5-Year ReturnCumulative with dividends-67.8%-72.0%
10-Year ReturnCumulative with dividends-67.8%-72.0%
CAGR (3Y)Annualised 3-year return-32.2%-38.4%
SBC leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

SBC leads this category, winning 2 of 2 comparable metrics.

SBC is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than LASE's 1.68 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBC currently trades 55.8% from its 52-week high vs LASE's 10.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSBC logoSBCSBC Medical Group…LASE logoLASELaser Photonics C…
Beta (5Y)Sensitivity to S&P 5000.76x1.68x
52-Week HighHighest price in past year$5.75$6.77
52-Week LowLowest price in past year$2.97$0.38
% of 52W HighCurrent price vs 52-week peak+55.8%+10.7%
RSI (14)Momentum oscillator 0–10029.938.5
Avg Volume (50D)Average daily shares traded87K1.9M
SBC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricSBC logoSBCSBC Medical Group…LASE logoLASELaser Photonics C…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$9.00
# AnalystsCovering analysts1
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

SBC leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LASE leads in 1 (Valuation Metrics).

Best OverallSBC Medical Group Holdings … (SBC)Leads 4 of 6 categories
Loading custom metrics...

SBC vs LASE: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is SBC or LASE a better buy right now?

For growth investors, SBC Medical Group Holdings Incorporated (SBC) is the stronger pick with 6.

1% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). SBC Medical Group Holdings Incorporated (SBC) offers the better valuation at 6. 7x trailing P/E (7. 1x forward), making it the more compelling value choice. Analysts rate SBC Medical Group Holdings Incorporated (SBC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SBC or LASE?

Over the past 5 years, SBC Medical Group Holdings Incorporated (SBC) delivered a total return of -67.

8%, compared to -72. 0% for Laser Photonics Corporation (LASE). Over 10 years, the gap is even starker: SBC returned -67. 8% versus LASE's -72. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SBC or LASE?

By beta (market sensitivity over 5 years), SBC Medical Group Holdings Incorporated (SBC) is the lower-risk stock at 0.

76β versus Laser Photonics Corporation's 1. 68β — meaning LASE is approximately 122% more volatile than SBC relative to the S&P 500. On balance sheet safety, SBC Medical Group Holdings Incorporated (SBC) carries a lower debt/equity ratio of 6% versus 49% for Laser Photonics Corporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — SBC or LASE?

By revenue growth (latest reported year), SBC Medical Group Holdings Incorporated (SBC) is pulling ahead at 6.

1% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: Laser Photonics Corporation grew EPS 40. 5% year-over-year, compared to 15. 5% for SBC Medical Group Holdings Incorporated. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SBC or LASE?

SBC Medical Group Holdings Incorporated (SBC) is the more profitable company, earning 22.

7% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps 22. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SBC leads at 34. 2% versus -189. 3% for LASE. At the gross margin level — before operating expenses — SBC leads at 76. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SBC or LASE?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is SBC or LASE better for a retirement portfolio?

For long-horizon retirement investors, SBC Medical Group Holdings Incorporated (SBC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

76)). Laser Photonics Corporation (LASE) carries a higher beta of 1. 68 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SBC: -67. 8%, LASE: -72. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SBC and LASE?

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SBC is a small-cap deep-value stock; LASE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SBC

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 14%
Run This Screen
Stocks Like

LASE

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Gross Margin > 18%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SBC and LASE on the metrics below

Revenue Growth>
%
(SBC: -18.3% · LASE: 28.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.